Reaction Details |
| Report a problem with these data |
Target | Nuclear receptor subfamily 4 group A member 2 |
---|
Ligand | BDBM50101853 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2227564 (CHEMBL5141077) |
---|
EC50 | 3000±n/a nM |
---|
Citation | Willems, S; Merk, D Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration. J Med Chem65:9548-9563 (2022) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Nuclear receptor subfamily 4 group A member 2 |
---|
Name: | Nuclear receptor subfamily 4 group A member 2 |
Synonyms: | NOT | NR4A2 | NR4A2_HUMAN | NURR1 | TINUR |
Type: | PROTEIN |
Mol. Mass.: | 66603.77 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_453027 |
Residue: | 598 |
Sequence: | MPCVQAQYGSSPQGASPASQSYSYHSSGEYSSDFLTPEFVKFSMDLTNTEITATTSLPSF
STFMDNYSTGYDVKPPCLYQMPLSGQQSSIKVEDIQMHNYQQHSHLPPQSEEMMPHSGSV
YYKPSSPPTPTTPGFQVQHSPMWDDPGSLHNFHQNYVATTHMIEQRKTPVSRLSLFSFKQ
SPPGTPVSSCQMRFDGPLHVPMNPEPAGSHHVVDGQTFAVPNPIRKPASMGFPGLQIGHA
SQLLDTQVPSPPSRGSPSNEGLCAVCGDNAACQHYGVRTCEGCKGFFKRTVQKNAKYVCL
ANKNCPVDKRRRNRCQYCRFQKCLAVGMVKEVVRTDSLKGRRGRLPSKPKSPQEPSPPSP
PVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGW
AEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFG
EWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVT
FNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF
|
|
|
BDBM50101853 |
---|
n/a |
---|
Name | BDBM50101853 |
Synonyms: | (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid | (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid | 11alpha,15alpha-dihydroxy-9-oxo-13-trans-prostenoic acid | ALPROSTADIL | CHEMBL495 | PGE-1 | PGE1 | prostaglandin E1 |
Type | Small organic molecule |
Emp. Form. | C20H34O5 |
Mol. Mass. | 354.481 |
SMILES | CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O |r| |
Structure |
|